| Entry |
|
|---|
| Name |
Prothionamide (JP18);
Protionamide (INN);
Trevintix (TN) |
|---|
| Abbr |
PTO |
|---|
| Formula |
C9H12N2S
|
|---|
| Exact mass |
180.0721
|
|---|
| Mol weight |
180.27
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antibacterial (tuberculostatic) |
|---|
| Comment |
Thiocarbamide derivative
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J04 ANTIMYCOBACTERIALS
J04A DRUGS FOR TREATMENT OF TUBERCULOSIS
J04AD Thiocarbamide derivatives
J04AD01 Protionamide
D01195 Prothionamide (JP18)
Drug groups [BR:br08330]
Antibacterial
DG01966 Antitubercular
DG01788 Thiocarbamide derivative
D01195 Prothionamide
Antimicrobials [BR:br08307]
Antibacterials
Other antibacterials
Mycolic acid biosynthesis inhibitor
D01195 Prothionamide (JP18)
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Other antibacterials
Mycolic acid biosynthesis inhibitor
D01195 Prothionamide (JP17)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01195 Prothionamide
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 12
1 C8y C 27.1925 -18.4288
2 C8x C 25.9796 -19.1285
3 C8x C 27.1925 -17.0294
4 C2c C 28.3994 -19.1285
5 C8y C 24.7610 -18.4288
6 C8x C 25.9796 -16.3240
7 N1a N 29.6062 -18.4288
8 S0 S 28.3878 -20.5278
9 N5x N 24.7610 -17.0294
10 C1b C 23.5483 -19.1285
11 C1b C 22.3355 -18.4288
12 C1a C 21.1277 -19.1268
BOND 12
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 2
5 3 6 1
6 4 7 1
7 4 8 2
8 5 9 1
9 5 10 1
10 10 11 1
11 6 9 2
12 11 12 1
|
|---|
